Adenovirus I-Leader Truncation Bioselected Against Cancer-Associated Fibroblasts to Overcome Tumor Stromal Barriers

Molecular Therapy - United States
doi 10.1038/mt.2011.159
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Stromal Markers of Activated Tumor Associated Fibroblasts Predict Poor Survival and Are Associated With Necrosis in Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2019English

Responsiveness of Stromal Fibroblasts to IFN- Blocks Tumor Growth via Angiostasis

Journal of Immunology
AllergyImmunology
2009English

Photosensitizer-Encapsulated Ferritins Mediate Photodynamic Therapy Against Cancer-Associated Fibroblasts and Improve Tumor Accumulation of Nanoparticles

English

Cancer-Associated Fibroblasts Share Characteristics and Pro-Tumorigenic Activity With Mesenchymal Stromal Cells

Cancer Research
Cancer ResearchOncology
2017English

Engineering Nanoparticles to Overcome Barriers to Immunotherapy

2019English

Tumor-Associated Stromal Cells as Key Contributors to the Tumor Microenvironment

Breast Cancer Research
Cancer ResearchOncology
2016English

Potent Antitumor Effect of Tumor Microenvironment-Targeted Oncolytic Adenovirus Against Desmoplastic Pancreatic Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Tumorigenic Responses of Cancer-Associated Stromal Fibroblasts After Ablative Radiotherapy: A Transcriptome-Profiling Study

Journal of Cancer Therapy
2013English

Correction: Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors Against Neoplastic and Stromal Cells in Pancreatic Cancer

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy